← Back to Analyst Consensus 
ONCY Buy
ONCOLYTICS BIOTECH INC
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 19, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 26, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Nov 17, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $10 | 44% |
| Aug 13, 2025 | Lake Street | initiate | — → Buy | $7 | 47% |
| May 21, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| May 16, 2025 | Jones Trading | downgrade | Buy → Hold | $0 | 50% |
| Mar 10, 2025 | Maxim Group | maintain | Buy → Buy | $3 | 41% |
| Mar 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Mar 10, 2025 | RBC Capital | maintain | Outperform → Outperform | $5 | 55% |
| Feb 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Nov 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Sep 19, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Aug 21, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| May 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Apr 4, 2024 | Raymond James | initiate | — → Outperform | $3 | 53% |
| Mar 8, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Feb 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Jan 19, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Jan 4, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Nov 13, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Aug 16, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Jun 29, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Jun 23, 2023 | Canaccord Genuity | reiterate | Buy → Buy | $5 | 48% |
| Jun 7, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| May 26, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| May 24, 2023 | JonesTrading | initiate | — → Buy | $9 | 75% |
| Mar 14, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $15 | 44% |
| Mar 6, 2023 | Canaccord Genuity | maintain | — → Buy | $5 | 48% |
| Oct 6, 2022 | Maxim Group | initiate | — → Buy | $3 | 41% |
| Feb 17, 2021 | HC Wainwright & Co. | initiate | — → Buy | $15 | 44% |
| May 11, 2020 | RBC Capital | maintain | — → Outperform | $6 | 55% |
| Sep 12, 2013 | Needham | initiate | — → Buy | $8 | 50% |
| Mar 4, 2013 | Piper Sandler | initiate | — → Overweight | $6 | 54% |
| Dec 18, 2012 | Bloom Burton & Co. | downgrade | Buy → Hold | $0 | — |
| Sep 12, 2012 | Bloom Burton & Co. | maintain | — → Buy | $4 | — |
| Aug 30, 2012 | Stifel | initiate | — → Buy | $6 | 53% |
Price Target Trend
May 24, 2026 Oct 27, 2026
EPS Estimates
0q —
0y —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days